ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $571 | -55.9% | 282,900 | -35.5% | 0.00% | -50.0% |
| Q2 2023 | $1,294 | +65.9% | 438,800 | +40.7% | 0.00% | +100.0% |
| Q1 2023 | $780 | +200.0% | 311,865 | +279.9% | 0.00% | – |
| Q4 2022 | $260 | -100.0% | 82,100 | -65.1% | 0.00% | -100.0% |
| Q3 2022 | $698,000 | +38.2% | 235,003 | +528.4% | 0.00% | 0.0% |
| Q1 2022 | $505,000 | -65.9% | 37,400 | -67.1% | 0.00% | -50.0% |
| Q4 2021 | $1,483,000 | +199.6% | 113,800 | +115.8% | 0.00% | +100.0% |
| Q3 2021 | $495,000 | – | 52,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |